| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
| Alport syndrome 2 | COL4A4* | Col4a4* | 5 models | Alliance of Genome Resources | ||
| Alport syndrome 2 | COL4A3* | Col4a3* | 5 models | Alliance of Genome Resources | |||
| autosomal dominant polycystic kidney disease | PKD2* | Pkd2* | 1 model | Alliance of Genome Resources | |||
| polycystic kidney disease 1 | PKD1* | Pkd1* | 28 models | Alliance of Genome Resources | |||
| polycystic kidney disease 2 | PKD2* | Pkd2* | 7 models | Alliance of Genome Resources | |||
| X-linked Alport syndrome | COL4A5* | Col4a5* | 3 models | Alliance of Genome Resources | |||
| Alport syndrome 2 | MPV17 | Mpv17* | 1 model | Alliance of Genome Resources | ||
| autosomal dominant polycystic kidney disease | BICC1 | Bicc1* | 1 model | Alliance of Genome Resources | |||
| autosomal dominant polycystic kidney disease | MYC | Myc* | 1 model | Alliance of Genome Resources | |||
| autosomal dominant polycystic kidney disease | NPHP3 | Nphp3* | 3 models | Alliance of Genome Resources | |||
| Alport syndrome | COL4A3* | Col4a3 | Alliance of Genome Resources | ||||
| Alport syndrome | COL4A5* | Col4a5 | Alliance of Genome Resources | ||||
| Alport syndrome | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| Alport syndrome 3A | COL4A3* | Col4a3 | Alliance of Genome Resources | ||||
| Alport syndrome 3A | MYH9* | Myh9 | Alliance of Genome Resources | ||||
| autosomal dominant polycystic kidney disease | MTOR* | Mtor | Alliance of Genome Resources | ||||
| autosomal dominant polycystic kidney disease | LRP5* | Lrp5 | Alliance of Genome Resources | ||||
| autosomal dominant polycystic kidney disease | PKD1* | Pkd1 | Alliance of Genome Resources | ||||
| polycystic kidney disease 3 | GANAB* | Ganab | Alliance of Genome Resources | ||||
| polycystic kidney disease 6 | DNAJB11* | Dnajb11 | Alliance of Genome Resources | ||||
| polycystic kidney disease 7 | ALG5* | Alg5 | Alliance of Genome Resources | ||||
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| autosomal dominant polycystic kidney disease | Tg(HBB-Myc)#Cos | 1 model | |
| polycystic kidney disease 1 | Tg(Pkd1*)39Mtru | 2 models | |
| polycystic kidney disease 2 | Tg(CAG-PKD2)#Hwl | 1 model | |